Robust group- but limited individual-level (longitudinal) reliability and insights into cross-phases response prediction of conditioned fear

  1. Maren Klingelhöfer-Jens  Is a corresponding author
  2. Mana R Ehlers
  3. Manuel Kuhn
  4. Vincent Keyaniyan
  5. Tina B Lonsdorf
  1. University Medical Center Hamburg-Eppendorf, Germany
  2. Harvard Medical School, United States

Abstract

Here we follow the call to target measurement reliability as a key prerequisite for individual-level predictions in translational neuroscience by investigating i) longitudinal reliability at the individual and ii) group level, iii) internal consistency and iv) response predictability across experimental phases. 120 individuals performed a fear conditioning paradigm twice six months apart. Analyses of skin conductance responses, fear ratings and BOLD-fMRI with different data transformations and included numbers of trials were conducted. While longitudinal reliability was rather limited at the individual level, it was comparatively higher for acquisition but not extinction at the group-level. Internal consistency was satisfactory. Higher responding in preceding phases predicted higher responding in subsequent experimental phases at a weak to moderate level depending on data specifications. In sum, the results suggest that while individual-level predictions are meaningful for (very) short time frames, they also call for more attention to measurement properties in the field.

Data availability

The data that support the findings of this study and the R Markdown files that generate this manuscript are openly available in Zenodo at https://doi.org/10.5281/zenodo.6359920.

The following data sets were generated

Article and author information

Author details

  1. Maren Klingelhöfer-Jens

    Institute for Systems Neuroscience, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
    For correspondence
    m.klingelhoefer-jens@uke.de
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5393-7871
  2. Mana R Ehlers

    Institute for Systems Neuroscience, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-1316-3787
  3. Manuel Kuhn

    Department of Psychiatry, Harvard Medical School, Belmont, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Vincent Keyaniyan

    Institute for Systems Neuroscience, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
    Competing interests
    The authors declare that no competing interests exist.
  5. Tina B Lonsdorf

    Institute for Systems Neuroscience, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-1501-4846

Funding

Deutsche Forschungsgemeinschaft (INST 211/633-2)

  • Tina B Lonsdorf

Deutsche Forschungsgemeinschaft (LO 1980/4-1)

  • Tina B Lonsdorf

Deutsche Forschungsgemeinschaft (LO 1980/7-1)

  • Tina B Lonsdorf

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Alexander Shackman, University of Maryland, United States

Ethics

Human subjects: All participants gave written informed consent to the protocol which was approved by the local ethics committee (PV 5157, Ethics Committee of the General Medical Council Hamburg). The study was conducted in accordance with the Declaration of Helsinki.

Version history

  1. Received: March 17, 2022
  2. Preprint posted: March 18, 2022 (view preprint)
  3. Accepted: September 12, 2022
  4. Accepted Manuscript published: September 13, 2022 (version 1)
  5. Accepted Manuscript updated: September 15, 2022 (version 2)
  6. Version of Record published: November 24, 2022 (version 3)

Copyright

© 2022, Klingelhöfer-Jens et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 780
    views
  • 148
    downloads
  • 8
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Maren Klingelhöfer-Jens
  2. Mana R Ehlers
  3. Manuel Kuhn
  4. Vincent Keyaniyan
  5. Tina B Lonsdorf
(2022)
Robust group- but limited individual-level (longitudinal) reliability and insights into cross-phases response prediction of conditioned fear
eLife 11:e78717.
https://doi.org/10.7554/eLife.78717

Share this article

https://doi.org/10.7554/eLife.78717

Further reading

    1. Developmental Biology
    2. Neuroscience
    Melody C Iacino, Taylor A Stowe ... Mark J Ferris
    Research Article

    Adolescence is characterized by changes in reward-related behaviors, social behaviors, and decision making. These behavioral changes are necessary for the transition into adulthood, but they also increase vulnerability to the development of a range of psychiatric disorders. Major reorganization of the dopamine system during adolescence is thought to underlie, in part, the associated behavioral changes and increased vulnerability. Here, we utilized fast scan cyclic voltammetry and microdialysis to examine differences in dopamine release as well as mechanisms that underlie differential dopamine signaling in the nucleus accumbens (NAc) core of adolescent (P28-35) and adult (P70-90) male rats. We show baseline differences between adult and adolescent stimulated dopamine release in male rats, as well as opposite effects of the a6 nicotinic acetylcholine receptor (nAChR) on modulating dopamine release. The a6-selective blocker, a-conotoxin, increased dopamine release in early adolescent rats, but decreased dopamine release in rats beginning in middle adolescence and extending through adulthood. Strikingly, blockade of GABAA and GABAB receptors revealed that this a6-mediated increase in adolescent dopamine release requires NAc GABA signaling to occur. We confirm the role of a6 nAChR and GABA in mediating this effect in vivo using microdialysis. Results herein suggest a multisynaptic mechanism potentially unique to the period of development that includes early adolescence, involving acetylcholine acting at a6-containing nAChRs to drive inhibitory GABA tone on dopamine release.

    1. Neuroscience
    Jongkyun Kang, Guodong Huang ... Jie Shen
    Research Article

    Mutations in leucine-rich repeat kinase 2 (LRRK2) are the most common genetic cause of Parkinson’s disease (PD). However, whether LRRK2 mutations cause PD and degeneration of dopaminergic (DA) neurons via a toxic gain-of-function or a loss-of-function mechanism is unresolved and has pivotal implications for LRRK2-based PD therapies. In this study, we investigate whether Lrrk2 and its functional homolog Lrrk1 play a cell-intrinsic role in DA neuron survival through the development of DA neuron-specific Lrrk conditional double knockout (cDKO) mice. Unlike Lrrk germline DKO mice, DA neuron-restricted Lrrk cDKO mice exhibit normal mortality but develop age-dependent loss of DA neurons, as shown by the progressive reduction of DA neurons in the substantia nigra pars compacta (SNpc) at the ages of 20 and 24 months. Moreover, DA neurodegeneration is accompanied with increases in apoptosis and elevated microgliosis in the SNpc as well as decreases in DA terminals in the striatum, and is preceded by impaired motor coordination. Taken together, these findings provide the unequivocal evidence for the cell-intrinsic requirement of LRRK in DA neurons and raise the possibility that LRRK2 mutations may impair its protection of DA neurons, leading to DA neurodegeneration in PD.